83257-010Level 3
JOBEVNE (bevacizumab-nwgd)
**Product type:** Human Prescription Drug
**Active ingredient:** BEVACIZUMAB
**Strength:** 25 mg/mL
**Dosage form:** Injection
**Route:** Intravascular
**Labeler:** Biocon Biologics Inc.
**Marketing category:** BLA (BLA761175)
**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
GET
/api/v1/systems/ndc_fda/nodes/83257-010Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.